Exercise training for cardiac amyloidosis
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This study tests a personalized exercise program for people with cardiac amyloidosis to see how it affects their heart and daily life. The goal is to help you feel better and stay active safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of cardiac amyloidosis, a condition where abnormal protein builds up in the heart and makes it stiff.
- You are able to do both endurance exercise (like walking, biking) and resistance training (like lifting light weights).
- Your heart medications are stable (not recently changed) and your heart condition is steady enough to participate.
- You have not had a heart attack, heart bypass surgery, or a shock from an implanted defibrillator in the last 6 months.
- You are not pregnant and do not have certain other heart conditions that could make exercise unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a 12-week supervised exercise program is safe and helpful for people with cardiac amyloidosis and heart failure. It aims to see if regular exercise can improve how you feel and function.
This study looks at how well people with cardiac amyloidosis can exercise and how that might relate to their long-term health. You'll do a supervised bike or treadmill test while your heart and lungs are monitored.
This study measures how well the heart’s tiny blood vessels work in people with cardiac amyloidosis, using special heart testing. It may help doctors understand the disease better and improve how patients are evaluated over time.
This study tests a new PET imaging agent (evuzamitide) to see if it can better detect cardiac amyloidosis when earlier tests were unclear. It may help confirm if the heart problem is related to TTR amyloid and guide further care.
This study uses signals from a pacemaker or defibrillator to help detect a condition called cardiac amyloidosis, where abnormal proteins build up in the heart. It may help diagnose this condition earlier without extra tests.
This trial tests whether setting your pacemaker to a slightly faster minimum heart rate (the 'lower rate') can improve your heart function and symptoms. It might help by making your heart beat more efficiently, potentially reducing fatigue and shortness of breath.
Hear when a new Cardiac Amyloidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.